Abstract
HSP22 (heat shock protein 22), belonging to the superfamily of small heat shock proteins, which has a molecular mass of 21.6KD and is able to exist in the form of monomer, has multiple functions including molecular chaperones, apoptosis and anti-apoptosis, lifespan extension, antioxidation and so on. In recent years, studies show that HSP22 plays a crucial role in many neurological diseases, such as hereditary nerve endings disease, Alzheimer disease and Charco-Marie-Tooth. This review explores the progress in HSP22 and its involvement in human neurological disease.
Keywords: HSP22, chaperone activity, protein-kinase, apoptosis, interaction, neurological disease, alpha-crystallin domain, autoimmune diseases, Hela cells, Trimerization, polyglutamine disease, chromatography, ultracentrifugation, immunocomplexes, ATP-dependent chaperones, Drosophila
Current Neurovascular Research
Title: HSP22 and its Role in Human Neurological Disease
Volume: 8 Issue: 4
Author(s): Xiaomei Guan, Chao Tu, Mengjun Li and Zhiping Hu
Affiliation:
Keywords: HSP22, chaperone activity, protein-kinase, apoptosis, interaction, neurological disease, alpha-crystallin domain, autoimmune diseases, Hela cells, Trimerization, polyglutamine disease, chromatography, ultracentrifugation, immunocomplexes, ATP-dependent chaperones, Drosophila
Abstract: HSP22 (heat shock protein 22), belonging to the superfamily of small heat shock proteins, which has a molecular mass of 21.6KD and is able to exist in the form of monomer, has multiple functions including molecular chaperones, apoptosis and anti-apoptosis, lifespan extension, antioxidation and so on. In recent years, studies show that HSP22 plays a crucial role in many neurological diseases, such as hereditary nerve endings disease, Alzheimer disease and Charco-Marie-Tooth. This review explores the progress in HSP22 and its involvement in human neurological disease.
Export Options
About this article
Cite this article as:
Guan Xiaomei, Tu Chao, Li Mengjun and Hu Zhiping, HSP22 and its Role in Human Neurological Disease, Current Neurovascular Research 2011; 8 (4) . https://dx.doi.org/10.2174/156720211798121034
DOI https://dx.doi.org/10.2174/156720211798121034 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Symmetry Plane Detection in Brain Image Analysis: A Survey
Current Medical Imaging New Antiepileptic Drugs: Molecular Targets
Central Nervous System Agents in Medicinal Chemistry Elevations in the Levels of NF-κB and Inflammatory Chemotactic Factors in the Brains with Alzheimer’s Disease - One Mechanism May Involve α3 Nicotinic Acetylcholine Receptor
Current Alzheimer Research Perinatal Events Affecting the Onset of Allergic Diseases
Current Drug Targets - Inflammation & Allergy Development of Crystalline Cellulosic Fibres for Sustained Release of Drug
Current Topics in Medicinal Chemistry Aldose Reductase: A Multi-disease Target
Current Enzyme Inhibition New Molecular and Cellular Targets for Chemoprevention and Treatment of Skin Tumors by Plant Polyphenols: A Critical Review
Current Medicinal Chemistry Mitochondrial, Metabolic and Genotoxic Effects of Antiretroviral Nucleoside Reverse-Transcriptase Inhibitors
Anti-Infective Agents in Medicinal Chemistry Effects of Gastrodia Elata Bl on Phencyclidine-Induced Schizophrenia-Like Psychosis in Mice
Current Neuropharmacology The Quest for a Tumor Suppressor Gene Phenotype
Current Molecular Medicine Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals
Current Pharmaceutical Design Glucocorticoid Analogues: Potential Therapeutic Alternatives for Treating Inflammatory Muscle Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders)
Recent Patents on CNS Drug Discovery (Discontinued) Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging
Current Molecular Imaging (Discontinued) Novel Aspects of Natural and Modified Vinca Alkaloids
Current Medicinal Chemistry - Anti-Cancer Agents Nano-antimicrobials: A New Paradigm for Combating Mycobacterial Resistance
Current Pharmaceutical Design Advances on Automatic Speech Analysis for Early Detection of Alzheimer Disease: A Non-linear Multi-task Approach
Current Alzheimer Research Traditional Chinese Medicine - Sea Urchin
Mini-Reviews in Medicinal Chemistry Therapy Against Ischemic Injury
Current Pharmaceutical Design Advances in the Treatment of Autoimmune Diseases; Cellular Activity, Type-1/Type-2 Cytokine Secretion Patterns and their Modulation by Therapeutic Peptides
Current Medicinal Chemistry